首页> 外国专利> Potential cardiotoxicity of compounds predicted based on the interaction of astemizole with the HERG (human ether-a-go-go-related gene) potassium channel

Potential cardiotoxicity of compounds predicted based on the interaction of astemizole with the HERG (human ether-a-go-go-related gene) potassium channel

机译:根据阿司咪唑与HERG(人类醚相关基因)钾通道的相互作用预测的化合物的潜在心脏毒性

摘要

Assays and kits are provided for the screening of test compounds for their capability to induce cardiotoxicity in a subject. The assays and kits are based on the finding that the interaction of astemizole with the HERG (Human Ether-a-go-go-Related Gene) potassium channel can be exploited to predict cardiotoxicity of compounds during the development of new therapeutics and other agents. Figure 1 A shows the saturation binding of [3H]-astemizole to cell membrane preparations of HEK293 cells stably transfected with the HERG channel cDNA. TB represents Total Binding measured, NSB represents Non Specific Binding measured and SB represents Specific Binding measured.
机译:提供了用于筛选测试化合物在受试者中诱导心脏毒性的能力的测定和试剂盒。该测定法和试剂盒基于以下发现:在开发新的治疗药物和其他药物时,可以利用阿斯咪唑与HERG(人类以太相关基因)钾通道的相互作用来预测化合物的心脏毒性。图1A显示了[3H]-阿司咪唑与用HERG通道cDNA稳定转染的HEK293细胞的细胞膜制剂的饱和结合。 TB代表测量的总结合,NSB代表测量的非特异性结合,SB代表测量的特异性结合。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号